Patient‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|3|521-529

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.3, 2018-02, pp. : 521-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of life and patient‐reported outcomes

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 3, 2018-02 ,pp. : 157-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tofacitinib With Methotrexate in Third‐Line Treatment of Patients With Active Rheumatoid Arthritis: Patient‐Reported Outcomes From a Phase III Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 4, 2015-04 ,pp. : 475-483

John Wiley & Sons Inc

Access to resources Recommend Favorite

What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1462-1470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T‐DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2–positive locally advanced or metastatic breast cancer

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 642-651

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base

By  

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 717-726

John Wiley & Sons Inc

Access to resources Recommend Favorite